Efflux of glutathione and glutathione complexes from human erythrocytes in response to vanadate

Blood Cells, Molecules, and Diseases

Volumn 50, Issue 1, 2013, Pages 1-7

  Cakir, Yeliz ^a   Yildiz, Deniz ^a  

^a MUSTAFA KEMAL UNIVERSITY   (Turkey)

Author keywords

Glutathione efflux; Human erythrocytes; Membrane transport; Vanadate

Indexed keywords

ADENOSINE; ARSENIC ACID; BICARBONATE CHLORIDE ANTIPORTER; GLUTATHIONE; LACTATE DEHYDROGENASE; NITRIC OXIDE; PROTEIN TYROSINE PHOSPHATASE; SUCCIMER; THIOL GROUP; VANADIC ACID;

ANION TRANSPORT; ARTICLE; COLORIMETRY; CONTROLLED STUDY; DRUG MECHANISM; DRUG RESPONSE; DRUG TRANSPORT; ERYTHROCYTE; ERYTHROCYTE MEMBRANE; HUMAN; HUMAN CELL; METHYLATION; PRIORITY JOURNAL; REACTION TIME; SICKLE CELL ANEMIA;

4,4'-DIISOTHIOCYANOSTILBENE-2,2'-DISULFONIC ACID; ADENOSINE; BIOLOGICAL TRANSPORT; CELLS, CULTURED; CHLORIDE-BICARBONATE ANTIPORTERS; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROCYTES; GLUTATHIONE; HUMANS; L-LACTATE DEHYDROGENASE; METHYLATION; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; PROPIONATES; QUINOLINES; SUCCIMER; SULFHYDRYL COMPOUNDS; VANADATES;

EID: 84869878959     PISSN: 10799796     EISSN: 10960961     Source Type: Journal    
DOI: 10.1016/j.bcmd.2012.07.001     Document Type: Article

References (50)

1. Shechter Y., Karlish S.J.D. Insulin-like stimulation of glucose oxidation in rat adipocytes by vanadyl (IV) ions. Nature 1980, 284:556-558.
2. Meyerovitch J., Farfel Z., Sack Y., Shechter Y. Oral administration of vandaate normalized blood glucose levels in streptozotocin-treated rats: characterization and mode of action. J. Biol. Chem. 1987, 262:6658-6662.
3. Goldfine A.B., Simonson D.C., Folli F., Patti M.E., Kahn C.R. In vivo and in vitro studies of vanadate in human and rodent diabetes mellitus. Mol. Cell. Biochem. 1995, 153:217-231.
4. Orvig C., Thompson K.H., Battle M., McNeill J.H. Vanadium compounds as insulin mimics. Met. Ions Biol. Syst. 1995, 31:575-594.
5. Goldfine A.B., Simonson D.C., Folli F., Patti M.E., Kahn C.R. Metabolic effects of sodium metavanadate in humans with insulin-dependent and noninsulin-dependent diabetes mellitus in vivo and in vitro studies. J. Clin. Endocrinol. Metab. 1995, 80:3311-3320.
6. Shechter Y. Insulin-mimetic effects of vanadate. Possible implications for future treatment of diabetes. Diabetes 1990, 39:1-5.
7. White M.F. The insulin signalling system and the IRS proteins. Diabetologia 1997, 40(2):S2-S17.
8. Cheatham B., Kahn C.R. Insulin action and the insulin signaling network. Endocr. Rev. 1995, 16(2):117-142.
9. Tamura S., Brown T.A., Whipple J.H., Fujita-Yamaguchi Y., Dubler R.E., Cheng K., Larner J. A novel mechanism for the insulin-like effect of vanadate on glycogen synthase in rat adipocytes. J. Biol. Chem. 1984, 259(10):6650-6658.
10. Fantus I.G., Ahmad F., Deragon G. Vanadate augments insulin-stimulated insulin receptor kinase activity and prolongs insulin action in rat adipocytes. Evidence for transduction of amplitude of signaling into duration of response. Diabetes 1994, 43(3):375-383.
11. Green A. The insulin-like effect of sodium vanadate on adipocyte glucose transport is mediated at a post-insulin-receptor level. Biochem. J. 1986, 238(3):663-669.
12. D'Onofrio F., Le M.Q., Chiasson J.L., Srivastava A.K. Activation of mitogen activated protein (MAP) kinases by vanadate is independent of insulin receptor autophosphorylation. FEBS Lett. 1994, 340(3):269-275.
13. Okada Y., Yoshida M., Baba S., Shii K. Development of vanadate sensitive human erythrocytes insulin receptor tyrosine phosphatase assay. Diabetes Res. Clin. Pract. 1998, 41(3):157-163.
14. Gregory H., Susana L., John K., Jason M., Paul P., Brian K., George T., Michael J., Gresser S., Chidambaram R. Mechanism of inhibition of protein-tyrosine phosphatases by vanadate and pervanadate. J.B.C. 1997, 272(2):843-851.
15. Swarup G., Cohen S., Garbers D.L. Inhibition of membrane phosphotyrosyl-protein phosphatase activity by vanadate. Biochem. Biophys. Res. Commun. 1982, 107(3):1104-1109.
16. Varecka L., Carafoli E. Vanadate-induced movements of Ca and K in human red blood cells. J.B.C. 1982, 257(13):7414-7421.
17. Varecka L., Peterajová E., Sevcík J. Ca(2+)-activated K+ channel and the activation of Ca2+ influx in vanadate-treated red blood cells. Gen. Physiol. Biophys. 1997, 16(4):339-357.
18. Kass G.E., Orrenius S. Calcium signaling and cytotoxicity. Environ. Health Perspect. 1999, 107(1):25-35.
19. Cortizo A.M., Bruzzone L., Molinuevo S., Etcheverry S.B. A possible role of oxidative stress in the vanadium-induced cytotoxicity in the MC3T3E1 osteoblast and UMR106 osteosarcoma cell lines. Toxicology 2000, 147(2):89-99.
20. Younes M., Strubelt O. Vanadate-induced toxicity towards isolated perfused rat livers: the role of lipid peroxidation. Toxicology 1991, 66:63-74.
21. Younes M., Kayser E., Strubelt O. Effect of antioxidants on vanadate-induced toxicity towards isolated perfused rat livers. Toxicology 1991, 70(2):141-149.
22. Gille G., Sigler K. Oxidative stress and living cells. Folia Microbiol. 1995, 40(2):131-152.
23. Clemens M.R., Waller H.D. Lipid peroxidation in erythrocytes. Chem. Phys. Lipids 1987, 45:251-268.
24. Eckert K.G., Eyer P. Formation and transport of xenobiotic glutathione-S-conjugates in red cells. Biochem. Pharmacol. 1986, 35:325-329.
25. Awasthi Y.C., Garg H.S., Dao D.D., Partridge C.A., Srivastava S.K. Enzymatic conjugation of erythrocyte glutathione with 1-chloro-2,4-dinitrobenzene: the fate of glutathione conjugate in erythrocytes and the effect of glutathione depletion on hemoglobin. Blood 1981, 58:733-738.
26. Ansari G.A.S., Singh S.V., Gan J.C., Awasthi Y.C. Human erythrocyte glutathione S-transferase: a possible marker of chemical exposure. Toxicol. Lett. 1987, 37:57-62.
27. Strange R.C., Jones P.W., Fryer A.A. Glutathione S-transferase: genetics and role in toxicology. Toxicol. Lett. 2000, 112:357-363.
28. Olive C., Board P. Glutathione S-conjugate transport by cultured human cells. Biochim. Biophys. Acta 1994, 1224:264-268.
29. Matsuda Y., Epstein L.F., Gatmaitan Z., Arias I.M. The role of thiols in ATP-dependent transport of S-(2,4-dinitrophenyl) glutathione by rat liver plasma membrane vesicles. Biochim. Biophys. Acta 1996, 1279:35-42.
30. Keppler D. Export pumps for glutathione S-conjugates. Free Radical Biol. Med. 1999, 27:985-991.
31. LaBelle E.F., Singh S.V., Srivastava S.K., Awasthi Y.C. Dinitrophenyl glutathione efflux from human erythrocytes is primary active ATP-dependent transport. Biochem. J. 1986, 238:443-449.
32. Sedlak J., Lindsay R.H. Determination of sulfhydryl groups in biological samples. Anal. Biochem. 1963, 25:192-205.
33. Welder A., Acosta D. Enzyme leakage as an indicator of cytotoxicity in cultured cells. Methods Toxicol. 1994, 18:46-49.
34. Delnomdedieu M., Basti M.M., Otvos J.D., Thomas D.J. Transfer of arsenite from glutathione to dithiols: a model of interaction. Chem. Res. Toxicol. 1993, 6(5):598-602.
35. Csanaky I., Gregus Z. Effect of phosphate transporter and methylation inhibitor drugs on the disposition of arsenate and arsenite in rats. Toxicol. Sci. 2001, 63:29-36.
36. Zhang T.L., Gao Y.X., Lu J.F., Wang K.J. Arsenite, arsenate and vanadate affect human erythrocyte membrane. Inorg. Bidotlessochem. 2000, 79(1-4):195-203.
37. Abraham M.I., Burckhardt G., Kempson S. Sodium-dependent phosphate transport in a rat kidney endosomal fraction. Kidney Int. 1992, 42:1070-1078.
38. 4 cotransporter is the molecular mechanism for Na/Li exchange in human red blood cells. Am. J. Physiol. Cell Physiol. 2003, 285:446-456.
39. 2+ cation with cystine. J. Trace Elem. Med. Biol. 1998, 12(1):56-58.
40. 2+-glutathione and related ligands: apotentiometric and spectroscopic study. J. Biol. Inorg. Chem. 2002, 7:225-240.
41. Dessì A., Micera G., Sanna D. EPR investigation of the oxovanadium(IV) complexes formed by the tripeptide glutathione and some related ligands in aqueous solution. J. Inorg. Biochem. 1993, 52(4):275-286.
42. Leslie E.M., Haimeur A., Waalkes M.P. Arsenic transport by the human multidrug resistance protein 1 (MRP1/ABCC1): evidence that a tri-glutathione conjugate is required. Biol. Chem. 2004, 279(31):32700-32708.
43. Kala S.V., Neely M.W., Kala G. The MRP2/cMOAT transporter and arsenic-glutathione complex formation are required for biliary excretion of arsenic. J. Biol. Chem. 2000, 275(43):33404-33408.
44. Abraham E.H., Sterling K.M., Kim R.J., Salikhova A.Y., Huffman H.B., Crockett M.A., Johnston N., Parker H.W., Boyle W.E., Hartov A., Demidenko E., Efird J., Kahn J., Grubman S.A., Jefferson D.M., Robson S.C., Thakar J.H., Lorico A., Rappa G., Sartorell A.C., Okunieff P. Erythrocyte membrane ATP Binding Cassette (ABC) proteins: MRP1 and CFTR as well as CD39 (Ecto-apyrase) involved in RBC ATP transport and elevated blood plasma ATP of cystic fibrosis. Blood Cells Mol. Dis. 2001, 27(1):165-180.
45. Klokouzas A., Wu Ch.P., Van Veen H.W., Barnard M.A., Hladky S.B. cGMP and glutathione-conjugate transport in human erythrocytes. The roles of the multidrug resistance-associated proteins, MRP1, MRP4 and MRP5. Eur. J. Biochem. 2003, 270:3696-3708.
46. Zaman G.J.R., Lankelma J., Tellingen O.V., Beijnens J., Dekker H., Paulusma C., Ronald P.J., Elferink O., Baas F., Brost P. Role of glutathione in the export of compounds from cells by the multidrug-resistance-associated protein. Proc. Natl. Acad. Sci. U. S. A. 1995, 92:7690-7694.
47. Sun H., Yan S.C., Cheng W.S. Interaction of antimony tartrate with the tripeptide glutathione implication for its mode of action. Eur. J. Biochem. 2000, 267:5450-5457.
48. Bentley R., Chasteen T.G. Microbial methylation of metalloids: arsenic, antimony, and Bismuth. Microbiol. Mol. Biol. Rev. 2002, 66(2):250-271.
49. Hayakawa T., Kobayashi Y., Cui X., Hirano S. A new metabolic pathway of arsenite: arsenic-glutathione complexes are substrates for human arsenic methyltransferase Cyt19. Arch. Toxicol. 2005, 79(4):183-191.
50. Naranmandura H., Suzuki N., Suzuki K.T. Trivalent arsenicals are bound to proteins during reductive methylation. Chem. Res. Toxicol. 2006, 19(8):1010-1018.